Proteomics Reveals Novel Oxidative and Glycolytic Mechanisms in Type 1 Diabetic Patients' Skin Which Are Normalized by Kidney-Pancreas Transplantation

Abstract

BackgroundIn type 1 diabetes (T1D) vascular complications such as accelerated atherosclerosis and diffused macro-/microangiopathy are linked to chronic hyperglycemia with a mechanism that is not yet well understood. End-stage renal disease (ESRD) worsens most diabetic complications, particularly, the risk of morbidity and mortality from cardiovascular disease is increased several fold.Methods and FindingsWe evaluated protein regulation and expression in skin biopsies obtained from T1D patients with and without ESRD, to identify pathways of persistent cellular changes linked to diabetic vascular disease. We therefore examined pathways that may be normalized by restoration of normoglycemia with kidney-pancreas (KP) transplantation. Using proteomic and ultrastructural approaches, multiple alterations in the expression of proteins involved in oxidative stress (catalase, superoxide dismutase 1, Hsp27, Hsp60, ATP synthase δ chain, and flavin reductase), aerobic and anaerobic glycolysis (ACBP, pyruvate kinase muscle isozyme, and phosphoglycerate kinase 1), and intracellular signaling (stratifin-14-3-3, S100-calcyclin, cathepsin, and PPI rotamase) as well as endothelial vascular abnormalities were identified in T1D and T1D+ESRD patients. These abnormalities were reversed after KP transplant. Increased plasma levels of malondialdehyde were observed in T1D and T1D+ESRD patients, confirming increased oxidative stress which was normalized after KP transplant.ConclusionsOur data suggests persistent cellular changes of anti-oxidative machinery and of aerobic/anaerobic glycolysis are present in T1D and T1D+ESRD patients, and these abnormalities may play a key role in the pathogenesis of hyperglycemia-related vascular complications. Restoration of normoglycemia and removal of uremia with KP transplant can correct these abnormalities. Some of these identified pathways may become potential therapeutic targets for a new generation of drugs.

Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology

“…In particular among those proteins, 30% were involved in the oxidative stress pathways. It is worth highlighting that several of the identified peptides (ATP synthase, calmodulin, albumin NADPH-flavin reductase, hemoglobin subunits, and peroxiredoxins) have already been associated with metabolic diseases and with different forms of diabetes, such as T1D (15). These data confirm that maintaining a stable redox state, which underlies the oxidative stress damage, is pivotal to counteract metabolic alterations and, Fig.…”

Role of Podocyte B7-1 in Diabetic Nephropathy

“…GFR was estimated from plasma concentrations of creatinine using the IDMS-traceable Modification of Diet in Renal Disease (MDRD) formula. 41 Individuals with evidence of nephropathy unrelated to diabetes and with CKD stages 4 and 5 42 were excluded.…”

Chaperonopathies and Chaperonotherapy. Hsp60 as Therapeutic Target in Cancer: Potential Benefits and Risks

“…Both Hsp60 and GroEL are involved in protein folding, working in combination with a co-chaperone, Hsp10 (GroES in bacteria) [26]. In eukaryotes, the Hsp60/Hsp10 molecular machinery is localized inside the mitochondria and is crucial for maintaining the mitochondrial respiratory-chain integrity and functionality and, consequently, cell survival [27,28]. This is valid not only in normal but also in tumor cells, in which Hsp60 levels are frequently increased especially in extramitochondrial sites (( Fig.…”